EMA GVP Annex III - Other Pharmacovigilance Guidance
These pharmacovigilance guidance documents were developed under the previous legal framework but are still valid in conjunction with GVP.
Click on the links below for full annex details
Guideline on the exposure to medicinal products during pregnancy: Need for post-authorisation data
First published: 14/11/2005, Last updated: 14/11/2005
First published: 03/08/2004, Last updated: 22/10/2010
First published: 20/11/2009, Last updated: 20/11/2009
First published: 01/02/2008, Last updated: 01/02/2008
EMA GVP Annex III: